Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
US Department of Justice
Merck
Citi
Teva
Daiichi Sankyo
Cipla
Baxter

Generated: June 23, 2018

DrugPatentWatch Database Preview

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for piperacillin sodium; tazobactam sodium and what is the scope of piperacillin sodium; tazobactam sodium freedom to operate?

Piperacillin sodium; tazobactam sodium
is the generic ingredient in three branded drugs marketed by Apollo Pharms Inc, Aurobindo Pharma Ltd, Fresenius Kabi, Fresenius Kabi Usa, Hospira Inc, Istituto Bio Ita Spa, Mylan Labs Ltd, Sandoz, Sandoz Inc, Wockhardt Bio Ag, and Wyeth Pharms Inc, and is included in eighteen NDAs. There are four patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Piperacillin sodium; tazobactam sodium has fifty-four patent family members in thirty-three countries.

There are sixteen drug master file entries for piperacillin sodium; tazobactam sodium. Thirteen suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
International Patents:54
US Patents:4
Tradenames:3
Applicants:11
NDAs:18
Drug Master File Entries: 16
Suppliers / Packagers: 13
Clinical Trials: 4
DailyMed Link:PIPERACILLIN SODIUM; TAZOBACTAM SODIUM at DailyMed
Pharmacology for PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Tentative approvals for PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up13.5G/VIALINJECTABLE;INJECTION
➤ Sign Up➤ Sign UpEQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIALINJECTABLE;INJECTION

US Patents and Regulatory Information for PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-001 Feb 24, 1998 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-002 Feb 24, 1998 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Sandoz Inc PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 203557-001 Oct 29, 2014 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-001 Feb 24, 1998 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,498,312 Compositions containing piperacillin and tazobactam useful for injection ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
UBS
Fish and Richardson
Deloitte
QuintilesIMS
Colorcon
McKinsey
Julphar
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.